Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Metformin vs Ketotifen in Melasma
NCT06942390Phase 2Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of metformin 1% gel, ketotifen in melasma, sponsored by Assiut University. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
metformin 1% gelketotifen
03
Conditions
melasma
Beyond the preview
Go deeper on NCT06942390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06942390.